Luckin Coffee to Announce Second Quarter 2025 Financial Results on July 30, 2025 GlobeNewswire July 23, 2025 BEIJING, July 23, 2025 (GLOBE NEWSWIRE) — Luckin Coffee Inc. (“Luckin Coffee” or the “Company”) (OTC: LKNCY) will release its second quarter 2025 financial results before the U.S. market opens on Wednesday, July 30, 2025. The Company will […]
Revolution Medicines Announces FDA Breakthrough Therapy Designation for Elironrasib GlobeNewswire July 23, 2025 Breakthrough Therapy Designation granted to elironrasib for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer who have received prior chemotherapy and immunotherapy but have not been previously treated with a KRAS G12C inhibitor Designation
Belite Bio to Participate in the BTIG Virtual Biotechnology Conference GlobeNewswire July 23, 2025 SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) — Belite Bio, Inc (NASDAQ: BLTE), a clinical-stage drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases that have significant unmet medical needs, today announced that the executive management team will
Ascentage Pharma to Participate in BTIG Virtual Biotechnology Conference 2025 GlobeNewswire July 23, 2025 ROCKVILLE, Md. and SUZHOU, China, July 23, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855) (“Ascentage Pharma” or the “Company“), a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced today that the Company's
Quanta Announces Leadership Team Appointment and Highlights Clinical Program Progress GlobeNewswire July 23, 2025 – 25-year industry veteran Vanessa L. Jacoby appointed CBO and CFO, bringing financial and strategic leadership – – Enrollment initiated in dose expansion cohorts in Phase 1 clinical trial of QTX3034, an oral G12D-preferring multi-KRAS inhibitor, in patients with KRASG12D-mutant pancreatic,
Respiree Closes US$11.6M Series A Financing Round Led by We Venture Capital and ClavystBio GlobeNewswire July 23, 2025 HOUSTON and SINGAPORE, July 23, 2025 (GLOBE NEWSWIRE) — Respiree, a health tech company developing artificial intelligence (AI) platforms to manage disease progression across the healthcare continuum, announced the successful closing of a US$11.6 million Series A
Cerro de Pasco Resources Common Shares Begin Trading on the Lima Stock Exchange GlobeNewswire July 23, 2025 MONTRÉAL, July 23, 2025 (GLOBE NEWSWIRE) — Cerro de Pasco Resources Inc. (TSXV: CDPR) (BVL: CDPR) (OTCMKTS: GPPRF) (FRA: N8HP) (“CDPR” or the “Company”) is pleased to announce that its common shares began trading on the Lima Stock
NevGold Announces Up to 92% Antimony Recovery From Positive Metallurgical Testwork Program at Oxide Gold-Antimony Limo Butte Project in Nevada GlobeNewswire July 23, 2025 Vancouver, British Columbia, July 23, 2025 (GLOBE NEWSWIRE) — NevGold Corp. (“NevGold” or the “Company“) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce extremely positive antimony (“Antimony”, “Sb”) metallurgical testwork results at
Fusion Fuel Receives First Payment in Sale of Shares of P2X Spain GlobeNewswire July 23, 2025 DUBLIN, July 23, 2025 (GLOBE NEWSWIRE) — via IBN – Fusion Fuel Green PLC (NASDAQ: HTOO) (“Fusion Fuel” or the “Company”), a provider of integrated energy solutions, today announced that it has received the first payment related to its
Upexi Purchases 83,000 SOL, Grows Treasury to 1.9 Million SOL Worth $381 Million GlobeNewswire July 23, 2025 TAMPA, Fla., July 23, 2025 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI) (the “Company” or “Upexi”), a brand owner specializing in the development, manufacturing and distribution of consumer products with diversification into the cryptocurrency space, today announced the